Rare diseases
Investigational molecules
Locations
Study of Darovasertib for Patients with Localized Uveal Melanoma
ItalyStudy of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment
ItalyStudy Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer
ItalyStudy of DCC-3116 with Sotorasib, Binimetinib, and Trametinib for Patients with Advanced or Metastatic Solid Tumors with RAS/MAPK Pathway Mutations
ItalyStudy of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
ItalyStudy on Patient Preference for Nivolumab and Relatlimab Administration Methods in Melanoma Patients
ItalyStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
ItalyStudy on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases
ItalyStudy on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients
ItalyStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
ItalyStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
ItalyStudy on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
